Identification of 27 allele-specific regulatory variants in Parkinson’s disease using a massively parallel reporter assay

被引:0
作者
Sophie L. Farrow
Sreemol Gokuladhas
William Schierding
Michael Pudjihartono
Jo K. Perry
Antony A. Cooper
Justin M. O’Sullivan
机构
[1] The University of Auckland,Liggins Institute
[2] The University of Auckland,The Maurice Wilkins Centre
[3] The University of Auckland,Department of Ophthalmology
[4] Garvan Institute of Medical Research,Australian Parkinsons Mission
[5] University of New South Wales,St Vincent’s Clinical School
[6] Agency for Science Technology and Research,Singapore Institute for Clinical Sciences
[7] University of Southampton,MRC Lifecourse Epidemiology Unit
来源
npj Parkinson's Disease | / 10卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Genome wide association studies (GWAS) have identified a number of genomic loci that are associated with Parkinson’s disease (PD) risk. However, the majority of these variants lie in non-coding regions, and thus the mechanisms by which they influence disease development, and/or potential subtypes, remain largely elusive. To address this, we used a massively parallel reporter assay (MPRA) to screen the regulatory function of 5254 variants that have a known or putative connection to PD. We identified 138 loci with enhancer activity, of which 27 exhibited allele-specific regulatory activity in HEK293 cells. The identified regulatory variant(s) typically did not match the original tag variant within the PD associated locus, supporting the need for deeper exploration of these loci. The existence of allele specific transcriptional impacts within HEK293 cells, confirms that at least a subset of the PD associated regions mark functional gene regulatory elements. Future functional studies that confirm the putative targets of the empirically verified regulatory variants will be crucial for gaining a greater understanding of how gene regulatory network(s) modulate PD risk.
引用
收藏
相关论文
共 115 条
[1]  
Chang D(2017)A meta-analysis of genome-wide association studies identifies 17 new Parkinson’s disease risk loci Nat. Genet. 49 1511-1516
[2]  
Nalls MA(2014)Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson’s disease Nat. Genet. 46 989-993
[3]  
Nalls MA(2019)Identification of novel risk loci, causal insights, and heritable risk for Parkinson’s disease: a meta-analysis of genome-wide association studies Lancet Neurol. 18 1091-1102
[4]  
Uffelmann E(2021)Genome-wide association studies. Methods Prim. 1 1-21
[5]  
Maurano MT(2012)Systematic Localization of Common Disease-Associated Variation in Regulatory DNA Science 337 1190-1195
[6]  
Porcu E(2019)Mendelian randomization integrating GWAS and eQTL data reveals genetic determinants of complex and clinical traits Nat. Commun. 10 1-12
[7]  
Blauwendraat C(2020)The genetic architecture of Parkinson’s disease Lancet Neurol. 19 170-178
[8]  
Nalls MA(2022)Nomenclature of Genetic Movement Disorders: Recommendations of the International Parkinson and Movement Disorder Society Task Force – An Update Mov. Disord. 37 905-935
[9]  
Singleton AB(2016)FINEMAP: efficient variable selection using summary data from genome-wide association studies Bioinformatics 32 1493-1501
[10]  
Lange LM(2018)From genome-wide associations to candidate causal variants by statistical fine-mapping Nat. Rev. Genet. 19 491-504